Epidural Stimulation for Spinal Cord Injury
(TSEPI Trial)
Trial Summary
What is the purpose of this trial?
This trial uses electrical stimulation of the lower spinal cord to help people with severe spinal cord injuries who can't move their legs or stand. The electrical signals aim to reactivate nerves, improving movement and other bodily functions. Electrical stimulation of the spinal cord has been used for pain relief, spasticity control, and movement restoration in spinal cord injury patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have an implanted pump or use nicotine, you may not be eligible to participate.
What data supports the effectiveness of the treatment Epidural Stimulation for Spinal Cord Injury?
Research shows that epidural stimulation can help people with spinal cord injuries regain some control over their muscles, allowing them to stand and make step-like movements. In one study, a person with paraplegia was able to stand and control muscle movements after just eight sessions of this treatment.12345
Is epidural stimulation safe for humans?
Epidural stimulation has been reported as safe and well-tolerated in patients, with studies showing it can reduce pain and improve function in various conditions. However, there can be specific cases like muscle hypertrophy (enlargement) due to electrode shifts, so monitoring and proper placement are important.26789
How is the treatment Epidural Stimulation for Spinal Cord Injury different from other treatments?
Epidural Stimulation is unique because it involves applying electrical stimulation directly to the spinal cord, which can help restore voluntary muscle control and improve standing and walking abilities in people with spinal cord injuries. Unlike other treatments, it directly interacts with the spinal circuits to enhance motor functions, offering a novel approach to rehabilitation.3591011
Research Team
Susan J Harkema, PhD
Principal Investigator
University of Louisville
Eligibility Criteria
This trial is for adults over 18 with severe spinal cord injury, unable to stand or move legs voluntarily, and experiencing issues like low blood pressure and respiratory dysfunction. They should be at least two years post-injury with stable health but can't join if they use nicotine, have certain implants, untreated conditions, or are pregnant.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive lumbosacral spinal cord epidural stimulation (scES) for cardiovascular function, voluntary movement, or standing with and/or without weight-bearing standing.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of cardiovascular, respiratory, bladder, bowel, and sexual function.
Open-label extension (optional)
Participants may opt into continuation of treatment long-term to further assess quality of life and healthcare costs.
Treatment Details
Interventions
- Epidural Stimulation
- Stand Training
Epidural Stimulation is already approved in United States, Canada, European Union for the following indications:
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Louisville
Lead Sponsor
Christopher Reeve Paralysis Foundation
Collaborator